{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:55:33Z","timestamp":1789678533076,"version":"4.0.1"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460584"],"award-info":[{"award-number":["82460584"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2025GXNSFBA069096, 2025GXNSFAA069022"],"award-info":[{"award-number":["2025GXNSFBA069096, 2025GXNSFAA069022"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alcohol-associated steatohepatitis (ASH) is a globally prevalent liver disease, with robust evidence implicating neutrophil extracellular traps (NETs) as a central pathological phenomenon driving inflammation and progression. However, the core genomic signatures that govern NETs and underlying molecular mechanisms within the ASH microenvironment remain poorly defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Building on the prominent NETs formation phenomenon in ASH, we established a core pool of NETs-related hub genes through intersection of ASH-derived differentially expressed genes (DEGs), key WGCNA modules, and a curated NETs gene set. From this NET-focused pool, a consensus of three machine learning algorithms (LASSO, SVM, RF) distilled a final diagnostic signature, which was rigorously validated in training and external cohorts via ROC analysis and neural networks. Patient heterogeneity was then investigated using consensus clustering with this signature, followed by immune profiling and functional validation in human and mouse ASH models. Therapeutic potential was explored through drug database enrichment and molecular docking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A NETs-focused three-gene signature (FOS, MMP7, CXCL6) achieved exceptional diagnostic accuracy for ASH (AUC = 1.00 in training; 0.983 in validation). It stratified ASH into a Metabolic-dominant (C1) subtype and a Pro-inflammatory (C2) subtype, the latter exhibiting higher MMP7\/CXCL6, lower FOS, and enriched cytotoxic infiltration.\n                      <jats:italic>In vivo<\/jats:italic>\n                      , FOS rose in acute injury but declined in chronic models and human ASH, whereas MMP7\/CXCL6 remained elevated, suggesting a temporal shift from acute FOS-dominant response to sustained MMP7\/CXCL6-mediated inflammation. Finally, drug-gene interaction analysis identified several potential therapeutic modulators, including N-acetylcysteine (NAC), with predicted high binding affinities to FOS and MMP7.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>FOS, MMP7, and CXCL6 constitute a clinically actionable signature capturing the stage-specific dynamics of NETs-driven inflammation in ASH. Beyond its diagnostic and stratifying utility, this signature highlights potential therapeutic avenues for clinical intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1711388","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:15:34Z","timestamp":1768367734000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A stage specific NETs-related signature in alcoholic steatohepatitis: from molecular subtyping to therapeutic vulnerabilities"],"prefix":"10.3389","volume":"16","author":[{"given":"Wei","family":"Gao","sequence":"first","affiliation":[{"name":"Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Bao","sequence":"additional","affiliation":[{"name":"Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangtao","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianxiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiping","family":"Yu","sequence":"additional","affiliation":[{"name":"Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglian","family":"Zeng","sequence":"additional","affiliation":[{"name":"Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]},{"name":"Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education","place":["Nanning, China"]},{"name":"Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"B1","unstructured":"Global status report on alcohol and health 2018\n          \n          450\n          \n          Geneva\n          World Health Organization\n          \n          2018"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-32483-3","volume-title":"Alcohol and Alcohol-related Diseases","author":"Mueller","year":"2023"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e176345","DOI":"10.1172\/JCI176345","article-title":"Alcohol-associated liver disease","volume":"134","author":"Mackowiak","year":"2024","journal-title":"J Clin Invest"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105170","article-title":"Alcohol-related liver disease: Basic mechanisms and clinical perspectives","volume":"22","author":"Liu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2207599","article-title":"Alcohol-associated hepatitis","volume":"387","author":"Bataller","year":"2022","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2022.12.005","article-title":"Alcoholic hepatitis: The rising epidemic","volume":"107","author":"Penninti","year":"2023","journal-title":"Med Clin North Am"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.35","article-title":"Alcoholic liver disease: mechanisms of injury and targeted treatment","volume":"12","author":"Louvet","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S2468-1253(19)30326-7","article-title":"The knowns and unknowns of treatment for alcoholic hepatitis","volume":"5","author":"Sehrawat","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41423-020-00560-0","article-title":"Neutrophils in liver diseases: pathogenesis and therapeutic targets","volume":"18","author":"Liu","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jhep.2022.08.029","article-title":"Neutrophil extracellular traps contribute to liver damage and increase defective low-density neutrophils in alcohol-associated hepatitis","volume":"78","author":"Cho","year":"2023","journal-title":"J Hepatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.05.017","article-title":"The role of neutrophils in alcohol-related hepatitis","volume":"79","author":"Khan","year":"2023","journal-title":"J Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00787-0","article-title":"Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases","volume":"23","author":"Wigerblad","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29914","article-title":"Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis","volume":"68","author":"van der Windt","year":"2018","journal-title":"Hepatol (Baltim Md)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-334318","article-title":"Stressed hepatocyte sustains alcohol-associated hepatitis progression by producing leukocyte cell-derived chemotaxin 2","volume":"74","author":"Xu","year":"2025","journal-title":"Gut"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0039","article-title":"Gut-derived lipopolysaccharide promotes alcoholic hepatosteatosis and subsequent hepatocellular carcinoma by stimulating neutrophil extracellular traps through toll-like receptor 4","volume":"28","author":"Liu","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-331447","article-title":"Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis","volume":"73","author":"Babuta","year":"2024","journal-title":"Gut"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S532908","article-title":"NLRP3 inflammasome activation in liver disorders: from molecular pathways to therapeutic strategies","volume":"18","author":"Ma","year":"2025","journal-title":"J Inflammation Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae205","article-title":"Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition","volume":"45","author":"Yang","year":"2024","journal-title":"Eur Heart J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-311861","article-title":"MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47phox-oxidative stress pathway in neutrophils","volume":"66","author":"Li","year":"2016","journal-title":"Gut"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.01.035","article-title":"The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis","volume":"64","author":"Bala","year":"2016","journal-title":"J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.18129\/B9.bioc.sva","article-title":"sva: surrogate variable analysis","author":"Leek","year":"2025"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1.30.1","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr Protoc Bioinform"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.18129\/B9.bioc.GSEABase","article-title":"GSEABase: Gene set enrichment data structures and methods","author":"Morgan","year":"2025"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v039.i05","article-title":"Regularization paths for cox\u2019s proportional hazards model via coordinate descent","volume":"39","author":"Simon","year":"2011","journal-title":"J Stat Softw"},{"key":"B29","first-page":"18","article-title":"Classification and regression by random forest","author":"Liaw","year":"2002"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinf"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.32614\/CRAN.package.neuralnet2","article-title":"neuralnet: training of neural networks","author":"Fritsch","year":"2019"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v085.i11","article-title":"NeuralNetTools: visualization and analysis tools for neural networks","volume":"85","author":"Beck","year":"2018","journal-title":"J Stat Softw"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2013.032","article-title":"Mouse model of chronic and binge ethanol feeding (the NIAAA model)","volume":"8","author":"Bertola","year":"2013","journal-title":"Nat Protoc"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2024-333222","article-title":"Alcohol-associated hepatitis: a neutrophile disease","volume":"74","author":"Brol","year":"2024","journal-title":"Gut"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.03.025","article-title":"Therapeutic advances in alcohol-associated hepatitis","volume":"76","author":"Szabo","year":"2022","journal-title":"J Hepatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160935","article-title":"Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation","volume":"214","author":"Bakiri","year":"2017","journal-title":"J Exp Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.stem.2021.07.001","article-title":"Establishment, maintenance, and recall of inflammatory memory","volume":"28","author":"Larsen","year":"2021","journal-title":"Cell Stem Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108656","article-title":"FOS licenses early events in stem cell activation driving skeletal muscle regeneration","volume":"34","author":"Almada","year":"2021","journal-title":"Cell Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s13059-023-03084-8","article-title":"In-organoid single-cell CRISPR screening reveals determinants of hepatocyte differentiation and maturation","volume":"24","author":"Liang","year":"2023","journal-title":"Genome Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-025-03370-2","article-title":"C-FOS promotes the formation of neutrophil extracellular traps and the recruitment of neutrophils in lung metastasis of triple-negative breast cancer","volume":"44","author":"Yan","year":"2025","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"B42","doi-asserted-by":"publisher","first-page":"8049","DOI":"10.1038\/s41467-025-63251-2","article-title":"Dysregulated RNA splicing impairs regeneration in alcohol-associated liver disease","volume":"16","author":"Chembazhi","year":"2025","journal-title":"Nat Commun"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e2503009","DOI":"10.1002\/advs.202503009","article-title":"CXCL6 reshapes lipid metabolism and induces neutrophil extracellular trap formation in cholangiocarcinoma progression and immunotherapy resistance","volume":"12","author":"He","year":"2025","journal-title":"Adv Sci (weinh Baden-wurtt Ger)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15701","article-title":"Multifunctional intracellular matrix metalloproteinases: implications in disease","volume":"288","author":"Bassiouni","year":"2021","journal-title":"FEBS J"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2015-0193OC","article-title":"Shedding of syndecan-1\/CXCL1 complexes by matrix metalloproteinase 7 functions as an epithelial checkpoint of neutrophil activation","volume":"55","author":"Gill","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.14217","article-title":"CXCL6 is a novel biliary marker and a downstream target of MMP7 in biliary atresia","volume":"55","author":"Kong","year":"2025","journal-title":"Hepatol Res: Off J Jpn Soc Hepatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000786","article-title":"Molecular mechanisms in MASLD\/MASH-related HCC","volume":"82","author":"Wang","year":"2025","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e09755","DOI":"10.1002\/advs.202509755","article-title":"Nutritional c-Fos induction rewires hepatic metabolism and can promote obesity-associated hepatocellular carcinoma","volume":"12","author":"Li","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101310","article-title":"BBOX1, LACC1, MMP7 and SSTR1 as common predictors in obesity and non-alcoholic fatty liver disease","volume":"12","author":"Huang","year":"2025","journal-title":"Genes Dis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156459","article-title":"CXCL6 promotes the progression of NAFLD through regulation of PPAR\u03b1","volume":"174","author":"Zou","year":"2024","journal-title":"Cytokine"},{"key":"B51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","article-title":"Immunological mechanisms and therapeutic targets of fatty liver diseases","volume":"18","author":"Wang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1038\/s41598-021-82315-z","article-title":"Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease","volume":"11","author":"Irvine","year":"2021","journal-title":"Sci Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2025.05.016","article-title":"Pharmacological strategies for the management of severe alcohol-associated hepatitis: A systematic review and meta-analysis","author":"Islam","year":"2025","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1711388\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:15:36Z","timestamp":1768367736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1711388\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2025.1711388"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1711388","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"article-number":"1711388"}}